National University Hospital testing Alzheimer's predictive AI from Korea

Singapore's National University Hospital is collaborating with medical AI company Heuron from South Korea to test the latter's AI solutions for screening and predicting Alzheimer's disease. 

Heuron delivered its two solutions: Heuron AD, which provides quantitative analysis on brain atrophy, and Heuron Brain PET, which provides fast and accurate PET tracer quantification.

Their year-long study will use approximately 700 brain MRI images and 230 brain PET scans from healthy patients, individuals with mild cognitive impairment, and those dealing with Alzheimer's from NUH. 

IHH Healthcare offers sleep AI solutions in clinics, hospitals

IHH Healthcare, Asia's largest private healthcare group, has made available an AI-powered wearable ring and software for diagnosing sleep apnoea and other sleep disorders across its global network of clinics and hospitals.

It recently invested in Hong Kong-based health technology company Belun, which received the first United States FDA approval for an AI-powered platform for sleep apnoea diagnosis.

In a media release, IHH said patients can take the Belun ring as a sleep test at home. The ring collects data which is then compiled into a clinical report for doctors who are helping manage their health.

IHH is also looking to further collaborate with Belun to address other health conditions related to sleep disorders. 

Indian heart hospital shifts to connected beds

As part of its new digital initiative, BM Birla Heart Hospital in India has introduced continuous remote patient monitoring in its wards.

It partnered with Dozee for its Enhanced Cardiac Care programme, which involves the deployment of its partner's AI-powered connected bed technology. The technology platform enables staff to remotely monitor patients' vital parameters, such as heart rate, blood pressure, and ECG. It also tracks trends in those measurements and alerts clinicians of signs of deterioration. 

BM Birla has initiated the programme to improve its capability to provide personalised care while promoting patient safety and outcomes and raising its standards of cardiac care delivery.